Additionally, with fibroblast differentiation, CCL19 expression generally showed a decreasing trend, with a slight increase during the late differentiation stage, while LOXL2 expression remained largely unchanged ( Figure 8J ).
← all excerpts
Identification of Novel Biomarkers and Potential Therapeutic Targets for Systemic Sclerosis: An Integrated Analysis of Plasma Proteome-Wide Mendelian Randomization and Transcriptome.
1
—
—